BiologyWorks™ was formed in 2019 to create simple, rapid diagnostic tests for infections, diseases, and contaminations. To better the lives of people throughout the world, by delivering affordable, accessible and accurate diagnostics where they live.
The company is ISO 13485-certified and is led by a veteran group of biologists, engineers, and creatives. With patent-protected technology based on years of research originating with the Alfred Mann Foundation, as well as underwritten by a grant from the Bill & Melinda Gates Foundation, BiologyWorks sits at the intersection of two important trends, telemedicine and diagnostics moving outside of centralized labs. While SARS-CoV-2 is our lead target, we are expanding our work to address additional critical infection and disease gene sequences.
We believe in access to reliable diagnostic testing for all. Providing certainty for individuals and their communities is what motivates us every day.